NRX Net Receivables from 2010 to 2025

NRXP Stock  USD 2.07  0.10  4.61%   
NRX Pharmaceuticals Net Receivables yearly trend continues to be relatively stable with very little volatility. Net Receivables is likely to drop to 5,130. During the period from 2010 to 2025, NRX Pharmaceuticals Net Receivables destribution of quarterly values had range of 831 K from its regression line and mean deviation of  355,048. View All Fundamentals
 
Net Receivables  
First Reported
2010-12-31
Previous Quarter
5.4 K
Current Value
5.1 K
Quarterly Volatility
395.6 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check NRX Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NRX Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Income of 372.8 K, Interest Expense of 131.1 K or Selling General Administrative of 20.3 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. NRX financial statements analysis is a perfect complement when working with NRX Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of NRX Pharmaceuticals Correlation against competitors.
To learn how to invest in NRX Stock, please use our How to Invest in NRX Pharmaceuticals guide.

Latest NRX Pharmaceuticals' Net Receivables Growth Pattern

Below is the plot of the Net Receivables of NRX Pharmaceuticals over the last few years. It is NRX Pharmaceuticals' Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NRX Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Net Receivables10 Years Trend
Slightly volatile
   Net Receivables   
0.07.0K6.0K5.4K5.1K100%
       Timeline  

NRX Net Receivables Regression Statistics

Arithmetic Mean572,783
Geometric Mean0.00
Coefficient Of Variation69.06
Mean Deviation355,048
Median831,000
Standard Deviation395,561
Sample Variance156.5B
Range831K
R-Value(0.80)
Mean Square Error59.3B
R-Squared0.65
Significance0.0002
Slope(66,807)
Total Sum of Squares2.3T

NRX Net Receivables History

2025 5130.0
2024 5400.0
2023 6000.0
2022 7000.0
2021null

About NRX Pharmaceuticals Financial Statements

NRX Pharmaceuticals shareholders use historical fundamental indicators, such as Net Receivables, to determine how well the company is positioned to perform in the future. Although NRX Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in NRX Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on NRX Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Net Receivables5.4 K5.1 K

Additional Tools for NRX Stock Analysis

When running NRX Pharmaceuticals' price analysis, check to measure NRX Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NRX Pharmaceuticals is operating at the current time. Most of NRX Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NRX Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NRX Pharmaceuticals' price. Additionally, you may evaluate how the addition of NRX Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
News Freq…Investor S…